|
| |
Price : 5 slide for 600 €
|
CX1 Human, skin cancer |
| |
|
|
|
|
|
|
|
Age |
Sex |
Diagnosis |
Site |
Stage |
|
1 |
53 |
M |
squamous cell carcinoma, well differentiated |
skin, face |
T2N0M0 |
|
2 |
54 |
M |
squamous cell carcinoma, well differentiated |
skin, scalp |
T3N0M0 |
|
3 |
62 |
M |
squamous cell carcinoma, well differentiated |
skin, neck |
T2N0M0 |
|
4 |
58 |
F |
squamous cell carcinoma, well differentiated |
skin, foot |
TXNXMX |
|
5 |
55 |
M |
squamous cell carcinoma, moderately differentiated |
skin neck |
T4N0M0 |
|
6 |
60 |
M |
squamous cell carcinoma, moderately differentiated |
skin, face |
T2N0M0 |
|
*7 |
57 |
M |
squamous cell carcinoma, moderately differentiated |
pharynx |
T4N0M0 |
|
8 |
61 |
M |
squamous cell carcinoma, well differentiated |
skin elbow |
T4N1M0 |
|
*9 |
25 |
F |
metastatic squamous cell carcinoma |
skin, scalp |
|
|
10 |
67 |
M |
squamous cell carcinoma, well differentiated |
skin, neck |
T4N0M0 |
|
11 |
63 |
M |
squamous cell carcinoma, poorly differentiated |
skin, perianal |
T2NXM0 |
|
12 |
63 |
M |
recurrent squamous cell carcinoma |
skin, face |
T4NXM0 |
|
*13 |
87 |
F |
squamous cell carcinoma, well differentiated |
skin face |
T1N0M0 |
|
*14 |
66 |
M |
squamous cell carcinoma, poorly differentiated |
skin, neck |
T4NXM0 |
|
15 |
48 |
M |
squamous cell carcinoma |
skin, axilla |
T4N12M1 |
|
16 |
65 |
M |
squamous cell carcinoma |
anus |
TXNXMX |
|
*17 |
67 |
M |
metastatic squamous cell carcinoma |
skin, chest wall |
3.5 cm |
|
18 |
48 |
M |
squamous cell carcinoma, moderately differentiated |
skin, lower leg |
T3N0M0 |
|
19 |
51 |
F |
squamous cell carcinoma, well differentiated |
skin, thigh |
T3N0M0 |
|
20 |
40 |
M |
squamous cell carcinoma, well differentiated |
skin, knee |
T4N0M0 |
|
21 |
40 |
M |
squamous cell carcinoma, well differentiated |
skin, lower leg |
T3N0M0 |
|
22 |
48 |
M |
squamous cell carcinoma, well differentiated |
skin, heel |
TXNXMX |
|
23 |
67 |
M |
squamous cell carcinoma |
skin, leg |
T3N0M0 |
|
24 |
80 |
F |
squamous cell carcinoma well differentiated |
skin, shoulder |
T1N0M0 |
|
25 |
70 |
M |
squamous cell carcinoma, poorly differentiated |
skin, abdomen |
TXNXM1 |
|
*26 |
66 |
M |
squamous cell carcinoma, moderately differentiated |
skin, neck |
3.5 cm |
|
*27 |
61 |
M |
metastatic squamous cell carcinoma |
skin, chest wall |
6 cm |
|
28 |
42 |
M |
recurrent squamous cell carcinoma |
skin, neck |
T4N1M0 |
|
29 |
50 |
M |
squamous cell carcinoma, well differentiated |
skin, lower leg |
T4N0M0 |
|
30 |
41 |
M |
recurrent squamous cell carcinoma |
skin, inguinal |
T3NXMX |
|
31 |
38 |
M |
squamous cell carcinoma, well differentiated |
skin, toe |
T4N0M0 |
|
*32 |
48 |
M |
recurrent squamous cell carcinoma |
skin, neck |
3.2 cm |
|
*33 |
54 |
M |
recurrent squamous cell carcinoma |
skin, neck |
3.5 cm |
|
34 |
42 |
M |
recurrent squamous cell carcinoma |
unkown |
T2N1M0 |
|
35 |
63 |
M |
squamous cell carcinoma, moderately differentiated |
skin, chest wall |
T4N1M1 |
|
*36 |
68 |
M |
metastatic squamous cell carcinoma |
skin, chest wall |
1.5 cm |
|
*37 |
64 |
F |
metastatic squamous cell carcinoma |
skin, abdomen |
2 cm |
|
38 |
55 |
M |
squamous cell carcinoma, well differentiated |
ear |
T2N1M0 |
|
39 |
42 |
M |
squamous cell carcinoma, well differentiated |
tongue |
T2N1M0 |
|
*40 |
58 |
M |
metastatic squamous cell carcinoma |
skin, neck |
10 cm |
|
41 |
75 |
M |
squamous cell carcinoma, well differentiated |
larynx |
2.5 cm |
|
*42 |
45 |
M |
squamous cell carcinoma, moderately differentiated |
skin, neck |
2.5 cm |
|
43 |
40 |
M |
squamous cell carcinoma, poorly differentiated |
skin, scalp |
T2N0M0 |
|
*44 |
72 |
M |
squamous cell carcinoma, well differentiated |
lung |
3.5 cm |
|
45 |
65 |
M |
squamous cell carcinoma, well differentiated |
skin, thigh |
T3N0M0 |
|
*46 |
66 |
M |
recurrent squamous cell carcinoma |
skin, neck |
1 cm |
|
47 |
80 |
F |
squamous cell carcinoma, well differentiated |
skin, buttock |
T2N0M0 |
|
48 |
73 |
F |
squamous cell carcinoma |
skin, wrist |
T1N0M0 |
|
49 |
47 |
M |
squamous cell carcinoma well differentiated |
skin, heel |
T2N0M0 |
|
50 |
74 |
M |
adenoid cystic carcinoma |
skin, axilla |
3.5 cm |
|
51 |
Normal of No. 1 |
|
|
|
|
|
52 |
Normal of No. 7 |
|
|
|
|
|
53 |
Normal of No. 8 |
|
|
|
|
|
54 |
Normal of No. 20 |
|
|
|
|
|
55 |
Normal of No. 38 |
|
|
|
|
|
56 |
Normal of No. 39 |
|
|
|
|
|
57 |
Normal of No. 42 |
|
|
|
|
|
58 |
Normal of No. 43 |
|
|
|
|
|
59 |
Normal of No. 45 |
|
|
|
|
|
60 |
carbon particle |
|
|
|
|
| |
|
|
|
|
|
General Information of the Tissue Array Slide :
Applications
- Immunohistochemistry
- In situ hybridization, RNA or DNA
- Fluorescent in situ hybridization (FISH)
- In situ PCR, RNA or DNA
- TUNEL for apoptosis (Recommended procedures in
www.tissue-array.com -> protocol)
Storage and stability
- Individual slide is paraffin-coated and put in an air-tight pack
with inert gas.
- Tissue array slides are shipped in room temperature.
- If the slides are stored in 4 degree, they are good up to one
year.
How processed
- Tissues were initially fixed with formalin except for some of the
animal tissues.
- Then, dehydrated with gradient ethanol; typically 1 hour each
progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
- Cleared by xylene, three changes for 1 hour each.
- Infiltrated with 60°C paraffin, three changes for 1 hour each
- Microtoming in 4 µm thickness and put on silane coating slide from
Muto Pure Chemicals (Japan)
Before use
- Dry slides for 1 hour in a oven at 60 degree.
- Dewax slides in xylene for 4 minutes x 5 times
- Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2
times each.
- Immerse slides in tap water for 5 minutes
Slide orientation
- In most of the slides with 59 or 60 cores, the orientation is as
below unless indicated otherwise. #60 location is usually filled with carbon
for orientation.
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
| 21 |
22 |
23 |
24 |
25 |
26 |
27 |
28 |
29 |
30 |
| 31 |
32 |
33 |
34 |
35 |
36 |
37 |
38 |
39 |
40 |
| 41 |
42 |
43 |
44 |
45 |
46 |
47 |
48 |
49 |
50 |
| 51 |
52 |
53 |
54 |
55 |
56 |
57 |
58 |
59 |
60 |
|